Volume 8, Issue 6, November 2020, Page: 161-165
Obesity and Endometrial Cancer: Increase in Frequency over a Period of 44 Years
Alfonso Torres Lobaton, Oncology Unit, General Hospital of Mexico, Mexico City, Mexico
Rosalva Barra Martinez, Oncology Unit, General Hospital of Mexico, Mexico City, Mexico
Elisa Paola Jimenez Arroyo, Oncology Unit, General Hospital of Mexico, Mexico City, Mexico
Juan Carlos Oliva Posada, Oncology Unit, General Hospital of Mexico, Mexico City, Mexico
Carla America Suarez Juarez, Diamond Tower, Metropolitan Angel’s Hospital, Mexico City, Mexico
Fred Morgan Ortiz, Research Center in Health Sciences, Autonomous University of Sinaloa, Mexico City, Mexico
Received: Oct. 7, 2020;       Accepted: Oct. 19, 2020;       Published: Oct. 30, 2020
DOI: 10.11648/j.jgo.20200806.12      View  58      Downloads  25
To draw attention to the increase in the frequency of endometrial cancer (CE) in recent decades and its association with overweight and obesity in a highly specialized institution. Retrospective study of patients with EC treated in the Oncology Service (OS) General Hospital of Mexico (GHM), in the years 2000 to 2017, obtaining information related to some risk factors and their classification. The data were compared with a previous study from the years 1966-1993. Of the record of 1,045 EC treated during the studied time of 44 years, 785 corresponded to the period 2000-2017 and 260 to the previous report, which meant an increase of 200% for this disease. Of gynecological cancers, the EC figures increased from 17.9% in 2010-2011 to 29.4% in 2016-2017 (p=0.0001). Overweight and obesity were in 572/785 (72.8%) of the current series vs. 120/260 (46.1%) of the previous series (p<0.05). An increase of 19% to 28% was found in women younger than 48 years when comparing the periods 2000 - 2009 vs. 2010-2017 (p=0.011); 119/389 classified as stage I, (30.5%) had risk factors for tumor recurrence and 378/898 (42.0%) had advanced malignancies. An increase in CE reported in this series and its association with overweight and obesity, may highlight the public health problem that this association represents in our country.
Obesity, Endometrial, Cancer, Increase, Frequency
To cite this article
Alfonso Torres Lobaton, Rosalva Barra Martinez, Elisa Paola Jimenez Arroyo, Juan Carlos Oliva Posada, Carla America Suarez Juarez, Fred Morgan Ortiz, Obesity and Endometrial Cancer: Increase in Frequency over a Period of 44 Years, Journal of Gynecology and Obstetrics. Vol. 8, No. 6, 2020, pp. 161-165. doi: 10.11648/j.jgo.20200806.12
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Santaballa A, Matías-Guiu X, Redondo A, Caballo N, et al. SEOM clinical guidelines for endometrial cancer (2017). Clin and Translat Oncol 2018; 20: 29-37. doi: 10.1007/s12094-017-1809-9.
Cancer Facts and Figures. American Cancer Society. 2018. Pag. 4.
Mexico. Source Globocan 2018. Number of new cases both sexes. International Agency for Research on Cancer. World Health Organization. 2018, p: 1-2.
Fernández CSB, Leon AG, Herrera TMC, et al. Perfil Epidemiológico de los tumores Malignos en México. Dirección General de Epidemiología (SINAIS/SINAVE/DGE/Salud). México D. F. Secretaría de Salud; 2011. p. 46-122.
Onstad AM, Schmandt ER, and Lu HK. Addressing de Role of Obesity. Endometrial Cancer Risk, Prevention, and treatment. J Clin Oncol. 2016; 34: 4225-4230. doi: 10.1200/JCO.2016.69.4638.
Nevadunsky SN, Arsdale Va, Strickler DH, Moadel A, et al, Obesity and Age at Diagnosis of Endometrial Cancer. Obstet Gynecol. 2014; 124: 300-306. Doi: 10.1097/AOG.0000000000000381.
Himbert C, Delphan M, Scherer D, Bowers WB, Stephen, and Cornelia M. Hursting C. Signals from the Adipose Microenvironment and the Obesity Cancer Link A Systematic Review. Cancer Prev Res. 2017; 10: 494–506. doi: 10.1158/1940-6207.CAPR-16-0322.
Campos NI, Cuevas NL, González CLD, Hernández BL, et al. Epidemiología de la obesidad y sus principales comorbilidades en México. En: La Obesidad en México. Estado de la política pública y recomendaciones para su prevención y control. Editores: Juan Ángel Rivera Dommarco, Maranta Colchero y col. Instituto Nacional de Salud Pública. México 2018. p: 31-38.
Encuesta Nacional de Salud y Nutrición 2018. Presentación de resultados. ensanut.insp.mx>informes>ensanut_2018_presentacion_resultados. 2019: p. 41.
Uterine Neoplasms. NCCN clinical Practice Guidelines in Oncology (NCCN Guidelines) 2019. Endo 4-10.
Creasman TW, Scott MD. Adenocarcinoma of the Uterine Corpus. In: Clinical Gynecologic Oncology Eds. Philip P Disaia, William T Creasman et al. Elsevier Ninth Ed. Philadelphia 2018. P. 131-135.
Torres LA, Plata NP, Cruz TF, et al. Cáncer ginecológico, 1983-1984. Frecuencia relativa y resultados del tratamiento. Unidad de Oncología. Hospital General de México. Rev Med Hosp Gen (Mex) 1987; 50: 169-177.
Torres LA, Amoretti C, Morgan OF. Cáncer ginecológico: evolución de su frecuencia relativa en una Institución de alta especialidad. Gac Mex Oncol (GAMO) 2014; 13: 222-228.
Torres LA, Flores VA, Rojo HG, Román BE, et al. Cáncer del endometrio en el Hospital General de México: 27 años de experiencia. Rev Inst Nal Cancerol (Mex) 1998; 44: 124-133.
Islami F, Torre AL, Drope MJ, Ward ME, et al. Gobal Cancer in Women: Cancer Control Priorities. Cancer Epidemiol Biomarkers Prev. 2017; 26: 458-70. doi: 10.1158/1055-9965.EPI-16-0871.
Browse journals by subject